
    
      1. Study Objective/ Aims Aim: - Rate of Her 2 positivity in 100 consecutive gastric cancer
           patients Primary Objective

           Test for Her 2 in 100 consecutive gastric cancer patients Immuno-histochemistry will be
           done in all patients. Patients with 2 and 3+ IHC will also have FISH done.

        2. Study Design& Methodology

           Patients will have the Her2 tested in 100 consecutive gastric cancer samples by
           immunohistochemistry and patients with 2+ and 3+ result will also have FISH done. This
           will not affect patient management

        3. Overview of Data collection Dr.Bhawna Sirohi the principal investigators will maintain
           and supervise data collection and maintaining records. The patient will be
           de-identified.

        4. Selection of Study Population

      Inclusion Criteria:

      100 consecutive patients with gastric cancer who have a pathology specimen at TMH

      Exclusion Criteria:

      If histopathology blocks were not available

      5) Sample size 100 to be enrolled. Patient consent waiver applied for as this does not affect
      patient care 6) Statistical Analysis It is an Observational study so Results will be given as
      %age of total population.
    
  